RT @nancydevlin1: Paper by me & @aj_lloyduk on 2 'preference-based' PROs: EQ-5D-5L & cancer-specific FACT-8D: 5L 'showed equally good conve…
RT @nancydevlin1: Paper by me & @aj_lloyduk on 2 'preference-based' PROs: EQ-5D-5L & cancer-specific FACT-8D: 5L 'showed equally good conve…
RT @nancydevlin1: Paper by me & @aj_lloyduk on 2 'preference-based' PROs: EQ-5D-5L & cancer-specific FACT-8D: 5L 'showed equally good conve…
RT @nancydevlin1: Paper by me & @aj_lloyduk on 2 'preference-based' PROs: EQ-5D-5L & cancer-specific FACT-8D: 5L 'showed equally good conve…
Paper by me & @aj_lloyduk on 2 'preference-based' PROs: EQ-5D-5L & cancer-specific FACT-8D: 5L 'showed equally good convergent validity, similar levels of responsiveness & outperformed FACT-8D in terms of known groups’ validity' 👉https://t.co/o
RT @aj_lloyduk: With colleagues from @OHEnews and @JanssenUK we have demonstrated that EQ-5D-5L is as sensitive as FACT-8D for measuring he…
RT @aj_lloyduk: With colleagues from @OHEnews and @JanssenUK we have demonstrated that EQ-5D-5L is as sensitive as FACT-8D for measuring he…
RT @aj_lloyduk: With colleagues from @OHEnews and @JanssenUK we have demonstrated that EQ-5D-5L is as sensitive as FACT-8D for measuring he…
With colleagues from @OHEnews and @JanssenUK we have demonstrated that EQ-5D-5L is as sensitive as FACT-8D for measuring health of lymphoma patients https://t.co/jJ1YDpcQJt
Testing the validity and responsiveness of a new cancer-specific health utility measure (FACT-8D) in relapsed/refractory mantle cell lymphoma, and comparison to EQ-5D-5L. #lymphoma #lymsm https://t.co/YCMxmvqCwA
Testing the validity and responsiveness of a new cancer-specific health utility measure (FACT-8D) in relapsed/refractory mantle cell lymphoma, and comparison to EQ-5D-5L https://t.co/cOVDbLxYUY
Testing the validity and responsiveness of a new cancer-specific health utility measure (FACT-8D) in relapsed/refractory mantle cell lymphoma, and comparison to EQ-5D-5L https://t.co/f2HKVDi85Q
New article: Testing the validity and responsiveness of a new cancer-specific health utility measure (FACT-8D) in relapsed/refractory mantle cell lymphoma, and comparison to EQ-5D-5L. https://t.co/Gc1vOoNoie #livercancer #oncology